l 663581 has been researched along with beta-carboline-3-carboxylic acid methyl ester in 1 studies
| Studies (l 663581) | Trials (l 663581) | Recent Studies (post-2010) (l 663581) | Studies (beta-carboline-3-carboxylic acid methyl ester) | Trials (beta-carboline-3-carboxylic acid methyl ester) | Recent Studies (post-2010) (beta-carboline-3-carboxylic acid methyl ester) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 145 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadingham, KL; Palmer, KJ; Thompson, SA; Wafford, KA; Whiting, PJ | 1 |
1 other study(ies) available for l 663581 and beta-carboline-3-carboxylic acid methyl ester
| Article | Year |
|---|---|
Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Base Sequence; Benzodiazepines; Benzodiazepinones; Carbolines; Flumazenil; Flunitrazepam; GABA Modulators; Humans; Molecular Sequence Data; Pyrazoles; Pyridazines; Pyridines; Receptors, GABA-A; Recombinant Proteins; Sequence Homology, Amino Acid; Triazolam; Xenopus; Zolpidem | 1995 |